These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 12058699)
1. Abacavir hypersensitivity reaction. AIDS Patient Care STDS; 2002 May; 16(5):242. PubMed ID: 12058699 [No Abstract] [Full Text] [Related]
2. Prospective HLA-B*5701 screening and abacavir hypersensitivity: a single centre experience. Waters LJ; Mandalia S; Gazzard B; Nelson M AIDS; 2007 Nov; 21(18):2533-4. PubMed ID: 18025891 [TBL] [Abstract][Full Text] [Related]
3. Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study. Rauch A; Nolan D; Martin A; McKinnon E; Almeida C; Mallal S Clin Infect Dis; 2006 Jul; 43(1):99-102. PubMed ID: 16758424 [TBL] [Abstract][Full Text] [Related]
4. Genetic screening to prevent abacavir hypersensitivity reaction: are we there yet? Phillips EJ Clin Infect Dis; 2006 Jul; 43(1):103-5. PubMed ID: 16758425 [No Abstract] [Full Text] [Related]
5. HLA-B*5701 screening for susceptibility to abacavir hypersensitivity. Lucas A; Nolan D; Mallal S J Antimicrob Chemother; 2007 Apr; 59(4):591-3. PubMed ID: 17317695 [TBL] [Abstract][Full Text] [Related]
6. Incidence of abacavir hypersensitivity and its relationship with HLA-B*5701 in HIV-infected patients in Taiwan. Sun HY; Hung CC; Lin PH; Chang SF; Yang CY; Chang SY; Chang SC J Antimicrob Chemother; 2007 Sep; 60(3):599-604. PubMed ID: 17631508 [TBL] [Abstract][Full Text] [Related]
7. Labeling changes for abacavir. AIDS Patient Care STDS; 2008 Aug; 22(8):683-4. PubMed ID: 18721055 [No Abstract] [Full Text] [Related]
8. HLA- B*5701 Allele in HIV-infected Indian Children and its Association with Abacavir Hypersensitivity. Manglani MV; Gabhale YR; Lala MM; Sekhar R; More D Indian Pediatr; 2018 Feb; 55(2):140-141. PubMed ID: 29242412 [TBL] [Abstract][Full Text] [Related]
9. Hypersensitivity reactions in patients treated with abacavir: strategies to avoid such reactions. Kapoor S AIDS Patient Care STDS; 2008 Oct; 22(10):769. PubMed ID: 18778242 [No Abstract] [Full Text] [Related]
10. Abacavir hypersensitivity reaction: an update. Hughes CA; Foisy MM; Dewhurst N; Higgins N; Robinson L; Kelly DV; Lechelt KE Ann Pharmacother; 2008 Mar; 42(3):387-96. PubMed ID: 18303141 [TBL] [Abstract][Full Text] [Related]
11. Current trends in screening across ethnicities for hypersensitivity to abacavir. Rodriguez-Nóvoa S; Soriano V Pharmacogenomics; 2008 Oct; 9(10):1531-41. PubMed ID: 18855539 [TBL] [Abstract][Full Text] [Related]
12. Studies on abacavir-induced hypersensitivity reaction: a successful example of translation of pharmacogenetics to personalized medicine. Guo Y; Shi L; Hong H; Su Z; Fuscoe J; Ning B Sci China Life Sci; 2013 Feb; 56(2):119-24. PubMed ID: 23393027 [TBL] [Abstract][Full Text] [Related]
13. Successful implementation of a national HLA-B*5701 genetic testing service in Canada. Lalonde RG; Thomas R; Rachlis A; Gill MJ; Roger M; Angel JB; Smith G; Higgins N; Trottier B Tissue Antigens; 2010 Jan; 75(1):12-8. PubMed ID: 19843279 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of HLA-B*57:01 allele in Argentinean HIV-1 infected patients. Moragas M; Belloso WH; Baquedano MS; Gutierrez MI; Bissio E; Larriba JM; Fay F; Aulicino P; Gurevich JM; Yaunguzian MF; Maldonado AC; Falistocco C; Sen L; Mangano A Tissue Antigens; 2015 Jul; 86(1):28-31. PubMed ID: 25922880 [TBL] [Abstract][Full Text] [Related]